Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement from the American Heart Association and American College of Cardiology

Circulation

Volumn 132, Issue 22, 2015, Pages e315-e325

  Zipes, Douglas P ^a   Link, Mark S ^b   Ackerman, Michael J ^c   Kovacs, Richard J ^a   Myerburg, Robert J ^d   Estes, N A Mark ^b  

^a INDIANA UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

AHA Scientific Statements; arrhythmias; athletes; cardiovascular abnormalities; conduction defects

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; ATHLETE; ATHLETIC PERFORMANCE; ATRIAL FIBRILLATION; CARDIOVASCULAR MALFORMATION; CLINICAL EVALUATION; COMPETITION; COMPLETE HEART BLOCK; ECHOCARDIOGRAPHY; EXERCISE TEST; FAINTNESS; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HUMAN; IMPLANTED HEART PACEMAKER; MEDICAL SOCIETY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REENTRY TACHYCARDIA; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SINUS ARRHYTHMIA; SINUS BRADYCARDIA; SPORTS MEDICINE; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOMATIC BRADYCARDIA; TRAINING; ADVISORY COMMITTEE; ARRHYTHMIAS, CARDIAC; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; CONGENITAL MALFORMATION; HEART MUSCLE CONDUCTION SYSTEM; PROCEDURES; STANDARDS; UNITED STATES;

ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; ARRHYTHMIAS, CARDIAC; ATHLETES; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; HEART CONDUCTION SYSTEM; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84949318048     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000245     Document Type: Article

References (39)

1. Zipes DP, Ackerman MJ, Estes NAM 3rd, Grant AO, Myerburg RJ, Van Hare G. Task Force 7: arrhythmias: 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45:1354-1363. doi: 10.1016/j.jacc.2005.02.014.
2. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) [published correction appears in Circulation. 2009;120:e34-e35]. Circulation. 2008;117:e350-e408. doi: 10.1016/CIRCULATIONAHA.108.189742.
3. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD, Ellenbogen KA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hayes DL, Page RL, Stevenson LW, Sweeney MO. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [corrected] [published correction appears in Circulation. 2013;127:e357-e359]. Circulation. 2012;126:1784-1800. doi: 10.1161/CIR.0b013e3182618569.
4. Kim JH, Noseworthy PA, McCarty D, Yared K, Weiner R, Wang F, Wood MJ, Hutter AM, Picard MH, Baggish AL. Significance of electrocardiographic right bundle branch block in trained athletes. Am J Cardiol. 2011;107:1083-1089. doi: 10.1016/j.amjcard.2010.11.037.
5. Fisch C, Zipes DP, McHenry PL. Rate dependent aberrancy. Circulation. 1973;48:714-724.
6. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, Cohen MH, Nordenberg A, Van Hare GF, Friedman RA, Perez M, Cecchin F, Schneider DS, Nehgme RA, Buyon JP. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol. 2001;37:238-242.
7. Bordachar P, Zachary W, Ploux S, Labrousse L, Haissaguerre M, Thambo JB. Pathophysiology, clinical course, and management of congenital complete atrioventricular block. Heart Rhythm. 2013;10:760-766. doi: 10.1016/j.hrthm.2012.12.030.
8. Furlanello F, Bertoldi A, Dallago M, Galassi A, Fernando F, Biffi A, Mazzone P, Pappone C, Chierchia S. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol. 1998;9(suppl):S63-S68.
9. Grimsmo J, Grundvold I, Maehlum S, Arnesen H. High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors: a 28-30 years follow-up study. Eur J Cardiovasc Prev Rehabil. 2010;17:100-105. doi: 10.1097/HJR.0b013e32833226be.
10. Page RL, Joglar JA, Al-Khatib SM, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. [published online ahead of print September 23, 2015]. Circulation. doi: 10.1161/CIR.0000000000000312.
11. Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck S, Van Casteren L, Alzand B, Willems R, Heidbuchel H. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011;13:1386-1393. doi: 10.1093/europace/eur142.
12. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS): endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9:632-696.e21. doi: 10.1016/j.hrthm.2011.12.016.
13. Pappone C, Manguso F, Santinelli R, Vicedomini G, Sala S, Paglino G, Mazzone P, Lang CC, Gulletta S, Augello G, Santinelli O, Santinelli V. Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med. 2004;351:1197-1205. doi: 10.1056/NEJMoa040625.
14. Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, Morady FJ, Paul T, Perry JC, Sanatani S, Tanel RE. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm. 2012;9:1006-1024.
15. Biffi A, Pelliccia A, Verdile L, Fernando F, Spataro A, Caselli S, Santini M, Maron BJ. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40:446-452.
16. Steriotis AK, Nava A, Rigato I, Mazzotti E, Daliento L, Thiene G, Basso C, Corrado D, Bauce B. Noninvasive cardiac screening in young athletes with ventricular arrhythmias. Am J Cardiol. 2013;111:557-562. doi: 10.1016/j.amjcard.2012.10.044.
17. Lampert R. Evaluation and management of arrhythmia in the athletic patient. Prog Cardiovasc Dis. 2012;54:423-431. doi: 10.1016/j. pcad.2012.01.002.
18. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Oxford, United Kingdom: Elsevier; 2010.
19. Heidbüchel H, Corrado D, Biffi A, Hoffmann E, Panhuyzen-Goedkoop N, Hoogsteen J, Delise P, Hoff PI, Pelliccia A; Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions, part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil. 2006;13:676-686. doi: 10.1097/01.hjr.0000239465.26132.29.
20. Biffi A, Maron BJ, Culasso F, Verdile L, Fernando F, Di Giacinto B, Di Paolo FM, Spataro A, Delise P, Pelliccia A. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol. 2011;107:697-703. doi: 10.1016/j.amjcard.2010.10.049.
21. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med. 2000;343:1355-1361. doi: 10.1056/NEJM200011093431902.
22. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53:1475-1487. doi: 10.1016/j. jacc.2009.02.007.
23. Dello Russo A, Pieroni M, Santangeli P, Bartoletti S, Casella M, Pelargonio G, Smaldone C, Bianco M, Di Biase L, Bellocci F, Zeppilli P, Fiorentini C, Natale A, Tondo C. Concealed cardiomyopathies in competitive athletes with ventricular arrhythmias and an apparently normal heart: role of cardiac electroanatomical mapping and biopsy. Heart Rhythm. 2011;8:1915-1922. doi: 10.1016/j.hrthm.2011.07.021.
24. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631-2671.
25. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69-72. doi: 10.1007/s10286-011-0119-5.
26. Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA. AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation. Circulation. 2006;113:316-327. doi: 10.1161/CIRCULATIONAHA.105.170274.
27. Link MS, Estes NA 3rd. How to manage athletes with syncope. Cardiol Clin. 2007;25:457-466, vii. doi: 10.1016/j.ccl.2007.07.005.
28. Grubb BP. Clinical practice. Neurocardiogenic syncope. N Engl J Med. 2005;352:1004-1010. doi: 10.1056/NEJMcp042601.
29. Asplund CA, O'Connor FG, Noakes TD. Exercise-associated collapse: an evidence-based review and primer for clinicians. Br J Sports Med. 2011;45:1157-1162. doi: 10.1136/bjsports-2011-090378.
30. Colivicchi F, Ammirati F, Santini M. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J. 2004;25:1749-1753. doi: 10.1016/j.ehj.2004.07.011.
31. Khoo C, Chakrabarti S, Arbour L, Krahn AD. Recognizing life-threatening causes of syncope. Cardiol Clin. 2013;31:51-66. doi: 10.1016/j. ccl.2012.10.005.
32. Krahn AD, Healey JS, Simpson CS, Chauhan VS, Birnie DH, Champagne J, Gardner M, Sanatani S, Chakrabarti S, Yee R, Skanes AC, Leong-Sit P, Ahmad K, Gollob MH, Klein GJ, Gula LJ, Sheldon RS. Sentinel symptoms in patients with unexplained cardiac arrest: from the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). J Cardiovasc Electrophysiol. 2012;23:60-66. doi: 10.1111/j.1540-8167.2011.02185.x.
33. O'Connor FG, Levine BD, Childress MA, Asplundh CA, Oriscello RG. Practical management: a systematic approach to the evaluation of exercise-related syncope in athletes. Clin J Sport Med. 2009;19:429-434. doi: 10.1097/JSM.0b013e3181b732c3.
34. Levine BD, Lane LD, Buckey JC, Friedman DB, Blomqvist CG. Left ventricular pressure-volume and Frank-Starling relations in endurance athletes: implications for orthostatic tolerance and exercise performance. Circulation. 1991;84:1016-1023.
35. Hastings JL, Levine BD. Syncope in the athletic patient. Prog Cardiovasc Dis. 2012;54:438-444. doi: 10.1016/j.pcad.2012.02.003.
36. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308-1339. doi: 10.1016/j. hrthm.2011.05.020.
37. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol. 2005;45:1318-1321. doi: 10.1016/j.jacc.2005.02.006.
38. Lampert R, Cannom D, Olshansky B. Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of Heart Rhythm Society members. J Cardiovasc Electrophysiol. 2006;17:11-15. doi: 10.1111/j.1540-8167.2005.00331.x.
39. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NA, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Law I, Loomis M, Barth C, Brandt C, Dziura J, Li F, Cannom D. Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry. Circulation. 2013;127:2021-2030. doi: 10.1161/CIRCULATIONAHA.112.000447.